The Treatment of Osteoarthritis
Overview
Affiliations
1. The treatment of osteoarthritis is currently purely symptomatic. To enable rational therapy, careful clinical assessment is necessary to identify the origin of symptoms. Often, effective therapy can result from a biomechanical approach such as surgery, orthotics, physiotherapy and dieting. If drugs are required, there is little evidence that the current over-reliance on non-steroidal anti-inflammatory drugs (NSAIDs) is justified. Full dose regular paracetamol should be the first line of analgesic therapy. In the majority of patients, simple analgesics are probably as effective as NSAIDs. If NSAIDs are used it is necessary to review regularly their use and to be aware of potential toxicity. 2. Many alternative strategies of pain management such as topical preparations, intra-articular steroid injections, acupuncture, radiosynovectomy, transcutaneous nerve stimulation and anti-depressants, may be effective but their precise place in the armamentarium is not yet fully established. 3. The realisation that osteoarthritis is not a passive 'wear and tear' phenomenon but an active process that may be potentially modified, has led to interest in 'chondroprotective' agents, which may beneficially affect the osteoarthritic process. To date there are no convincing data available that such agents are, in fact, chondroprotective in humans.
Paskins Z, Hughes G, Myers H, Hughes E, Hennings S, Cherrington A BMC Musculoskelet Disord. 2018; 19(1):218.
PMID: 30021588 PMC: 6052622. DOI: 10.1186/s12891-018-2153-0.
Pavelka K, Bruyere O, Cooper C, Kanis J, Leeb B, Maheu E Drugs Aging. 2016; 33(2):75-85.
PMID: 26849131 PMC: 4756045. DOI: 10.1007/s40266-016-0347-4.
Clinical efficacy of radiation synovectomy in digital joint osteoarthritis.
Kampen W, Hellweg L, Massoudi-Nickel S, Czech N, Brenner W, Henze E Eur J Nucl Med Mol Imaging. 2004; 32(5):575-80.
PMID: 15599524 DOI: 10.1007/s00259-004-1712-9.
Cyclooxygenase-2 inhibitors: promise or peril?.
Mengle-Gaw L, Schwartz B Mediators Inflamm. 2002; 11(5):275-86.
PMID: 12467519 PMC: 1781678. DOI: 10.1080/09629350290000041.
Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments.
Choy E, Scott D Drugs. 1997; 53(3):337-48.
PMID: 9074838 DOI: 10.2165/00003495-199753030-00001.